ABEVMY bevacizumab 400 mg/16 mL concentrate injection for solution vial

Aperçu du produit

About ABEVMY bevacizumab

ABEVMY bevacizumab is a medication containing the active ingredient Bevacizumab, classified as Vascular Endothelial Growth Factor Inhibitor. Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE MVASI is a vascular endothelial growth factor inhibitor indicated for the treatment of: Metastatic colorectal cancer, in.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Bevacizumab, the active ingredient in ABEVMY bevacizumab, belongs to the Vascular Endothelial Growth Factor Inhibitor class. 1 INDICATIONS AND USAGE MVASI is a vascular endothelial growth factor inhibitor indicated for the treatment of: Metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment. ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking ABEVMY bevacizumab. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use ABEVMY bevacizumab for extended periods without medical advice.